Table 1 Characteristics of participating units in the SES and the PPS
From: Comparison of two alternative study designs in assessment of medicines utilisation in neonates
| Â | SES | PPS | OR (95% CI) |
|---|---|---|---|
No of participating countries | 20 | 21 | NA |
No of participating hospitals | 102 | 73 | NA |
No of participating units | 115 | 89 | NA |
Median (IQR) No of participating units per country | 3.5 (1.75;7.75) | 3 (2;5) | NA |
No (%) of teaching hospitals | 62 (61%) | 56 (77%) | 0.47 (0.24-0.92) |
Level distribution (%) | Â | Â | Â |
Level 3 | 60 | 73 | 0.56 (0.31-1.03) |
Level 2 | 33 | 21 | 1.84 (0.97-3.50) |
Level 1 | 6 | 6 | 1.13 (0.35-3.69) |
Total annual live births in catchment area of participating units* (year of reference: 2010) | 593,001 | 349,465 | 1.89 (1.87-1.89) |
Regional proportions of live births covered (%)** | Â | Â | Â |
Eastern Europe | 10 | 4 | 2.79 (2.75-2.82) |
Northern Europe | 18 | 8 | 2.55 (2.53-2.57) |
Southern Europe | 12 | 9 | 1.30 (1.27-1.31) |
Western Europe | 6 | 4 | 1.65 (1.63-1.66) |
Annual number of admissions in participating units α | 90,599 | 72,132 | NA |
Annual admissions coverage; mean% (SD) ¥ | 3.95 (2.74) | 2.59 (1.48) | 1.58 (1.48-1.68) |
No of neonates in unit in the study period | 3080‡ | 1382 | NA |
No of neonates receiving any drug prescription during the study period | 2050 | 825 | 1.34 (1.18-1.53) |